Tag Archives: Treatment

Global $5.12 Bn Acne Treatment Market Opportunities and Forecast to 2024 – PRNewswire

DUBLIN, Dec. 4, 2019 /PRNewswire/ — The “Global Acne Treatment Market: World Market Review By Product Type, Applications, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024) – By Country (USA, Canada, Germany, France, UK, Italy, Spain, China, India, Mexico)” report has been added to ResearchAndMarkets.com’s offering. Global Acne Market was valued at USD… Read More »

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause

Weight gain after starting antiretroviral treatment probably has multiple causes but appears strongly linked to specific drugs, and to combinations of drugs, Dr Andrew Hill of the University of Liverpool told the 17th European AIDS Conference in Basel, Switzerland, on Thursday. He highlighted some of the problems with the ways in which the phenomenon has… Read More »

Sugar Headache Symptoms, Causes, Treatment, and Prevention – Greatist

Created for Greatist by the experts at Healthline. Read more Share on Pinterest Sugar is delicious. Sadly, it’s also a primary cause of all kinds of bodily troubles — including headaches. Though there are lots of ways to get a headache, sugar headaches are no fun. Thankfully, they’re fairly easy to prevent (and you won’t… Read More »

Weight gain on HIV treatment: more common with newer drugs, low CD4 counts

Weight gain after starting antiretroviral treatment is not exclusive to dolutegravir-based treatment, but appears to be associated with newer, better tolerated drugs, a large meta-analysis of randomised trials published this month in Clinical Infectious Diseases has found. People with low CD4 counts were at much greater risk of large weight increases after starting treatment, the… Read More »